The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …

SARS-CoV-2 variants of concern (VOC) have arisen independently at multiple locations 1 ,
2 and may reduce the efficacy of current vaccines that target the spike glycoprotein of SARS-…

The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …

SARS-CoV-2 Omicron (B.1.1.529) BA.4 and BA.5 sub-lineages, first detected in South Africa,
have changes relative to Omicron BA.1 including substitutions in the spike receptor binding …

Characterizing SARS-CoV-2 evolution in specific geographies may help predict properties
of the variants that come from these regions. We mapped neutralization of a SARS-CoV-2 …

Omicron BA.2.86 subvariant differs from Omicron BA.2 as well as recently circulating variants
by over 30 mutations in the spike protein alone. Here we report on the isolation of the live …

The extent to which Omicron infection 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 – 9 , with or without previous
vaccination, elicits protection against the previously dominant Delta (B.1.617.2) variant is …

The SARS-CoV-2 Omicron (B.1.1.529) variant first emerged as the BA.1 sub-lineage, with
extensive escape from neutralizing immunity elicited by previous infection with other variants, …

Omicron variant (B. 1.1. 529) infections are rapidly expanding worldwide, often in settings
where the Delta variant (B. 1.617. 2) was dominant. We investigated whether neutralizing …

Objective: HIV-infected patients with treated cryptococcal meningitis are at risk for further
neurological deterioration after commencing combination antiretroviral therapy (cART), mostly …